Uncharacterized protein ORFC in retron EC67 Antibody

What is retron Ec67 and how does ORFC function within this defense system?

Retron Ec67 is a bacterial defense system that protects bacteria against phage infection through an abortive infection mechanism. The system works by sensing specific phage-encoded proteins, particularly those involved in DNA degradation, and then activating effector proteins that disrupt the phage replication cycle . The ORFC protein appears to be part of this defense mechanism, though its specific function remains uncharacterized. Retron Ec67 shows considerable inhibition against T2 phage but only moderate inhibition against other T-even phages like T4 and T6, suggesting specificity in its targeting mechanism .

How does retron Ec67 detect phage infection, and what role might ORFC play?

Retron Ec67 detects phage infection by recognizing phage proteins involved in DNA degradation. Research has identified that phage mutants able to escape retron Ec67 defense carried mutations in DenB (in T2 phage) or protein A1 (in T5n/ΦSP15m phages) . Both proteins are involved in DNA degradation processes: DenB cleaves single-stranded DNA in a dC-specific manner, while protein A1 is responsible for host DNA degradation and shutoff of host genes . Co-expression of DenB and Ec67 significantly inhibited bacterial growth, suggesting that retron Ec67 defense may be triggered by the activity of these DNA-degrading enzymes . The ORFC protein may function within this detection pathway or in the subsequent effector response.

What experimental systems are currently used to study retron Ec67 proteins including ORFC?

Based on published research, several experimental approaches are employed to study retron Ec67 proteins:

• Phage infection assays on bacteria expressing retron Ec67

• Screening for phage mutants that can bypass retron Ec67 defense

• Co-expression of specific phage proteins with retron Ec67 to identify trigger mechanisms

• Exogenous expression of anti-retron proteins to study protection mechanisms

• Analysis of retron components (msDNA, ncRNA) to understand how anti-retron proteins affect the system

For uncharacterized proteins like ORFC specifically, researchers typically employ genetic approaches (gene knockout/complementation), protein expression and purification, and interaction studies with other retron components.

What is known about the genetic organization of ORFC within the retron Ec67 system?

While the complete genetic organization of ORFC within retron Ec67 is not fully detailed in current research, retrons typically consist of a reverse transcriptase (RT), non-coding RNA (msr-msd transcriptional cassettes), and one or more effector proteins . The effector proteins vary between different retron systems and are responsible for the toxic effects that lead to abortive infection. ORFC likely represents one of these components within the retron Ec67 genetic cluster, though its exact position and relationship to other genes require further characterization.

How do phages evade retron Ec67 defense, and would antibodies against ORFC help study this process?

Phages evade retron Ec67 through at least two mechanisms:

• Mutations in specific phage proteins: Phages develop mutations in proteins that trigger retron Ec67 (such as DenB in T2 phage or protein A1 in T5n/ΦSP15m phages) .

• Anti-retron proteins: Phages encode specific anti-defense proteins, such as Rad (retron anti-defense), which functions by degrading the non-coding RNA (ncRNA) of the retron, preventing further synthesis of retron components .

Antibodies against ORFC would be valuable tools to study how these evasion mechanisms affect ORFC expression, localization, or function during phage infection, potentially revealing whether phage counter-defenses specifically target this protein.

What are the molecular mechanisms by which ORFC might contribute to retron Ec67 function?

While the specific function of ORFC remains uncharacterized, it may participate in the retron Ec67 system through several potential mechanisms:

• Sensing phage determinants: It could function like other retron sensors that detect phage proteins involved in DNA manipulation .

• Signal transduction: ORFC might serve as an intermediary that communicates between the detection and effector components.

• Effector activity: Similar to PtuAB in retron Ec78 (which degrades tRNATyr), ORFC could have direct toxic activity against phage replication .

• Regulatory function: It might regulate the activation or deactivation of other retron components.

To determine its precise role, researchers should investigate ORFC's interaction partners, enzymatic activities, and effects on both bacterial and phage components during infection.

How might post-translational modifications affect ORFC protein function in retron systems?

Post-translational modifications (PTMs) could significantly impact ORFC function in several ways:

• Activation control: PTMs might serve as switches that activate or deactivate ORFC in response to phage infection.

• Localization: Modifications could direct ORFC to specific subcellular locations relevant to its function.

• Interaction regulation: PTMs might modulate ORFC's ability to interact with other retron components or phage targets.

• Stability regulation: Modifications could affect ORFC's stability and turnover rate during the defense response.

Methodologically, researchers should employ mass spectrometry-based approaches to identify potential PTMs on ORFC under various conditions (uninfected, phage-infected, with/without anti-retron factors), coupled with mutational studies of modified residues to determine their functional significance.

What approaches are most effective for identifying protein-protein interactions involving ORFC?

For studying ORFC protein interactions, researchers should consider these methodological approaches:

• Co-immunoprecipitation (Co-IP) using anti-ORFC antibodies followed by mass spectrometry to identify interaction partners

• Bacterial two-hybrid or yeast two-hybrid screens to systematically test for interactions between ORFC and other bacterial or phage proteins

• Proximity labeling approaches (such as BioID or APEX) to identify proteins in close proximity to ORFC during phage infection

• Crosslinking mass spectrometry to capture transient interactions

• Fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) to visualize ORFC interactions in live cells

• In vitro binding assays with purified components to confirm direct interactions

These methods should be applied across different conditions (resting state, during phage infection, in the presence of anti-retron factors) to fully map ORFC's interaction network.

How do mutations in phage proteins affect recognition by retron Ec67, and how could ORFC antibodies help study this process?

Specific mutations in phage proteins can allow phages to evade recognition by retron Ec67. Research identified single point mutations in DenB (T2 phage) or protein A1 (T5n/ΦSP15m phages) that enabled phages to bypass retron Ec67 defense . These mutations likely alter activities that are normally recognized by the retron system.

Antibodies against ORFC would enable several experimental approaches:

• Monitoring ORFC expression, localization, or modification state during infection with wild-type versus mutant phages

• Investigating whether ORFC directly interacts with phage proteins (wild-type or mutant versions) through co-immunoprecipitation

• Determining if ORFC undergoes conformational changes upon exposure to wild-type but not mutant phage proteins

• Assessing whether anti-retron factors like Rad affect ORFC stability or localization

These approaches would help determine ORFC's specific role in phage recognition or downstream defense activation.

What structural and functional domains might exist within ORFC, and how could they be characterized?

To characterize potential domains within ORFC:

• Bioinformatic analysis: Use sequence analysis tools to predict domains based on homology to known proteins and conserved motifs

• Limited proteolysis coupled with mass spectrometry: Identify stable domains resistant to proteolytic degradation

• Truncation analysis: Express and test the function of different ORFC fragments to map functional regions

• Site-directed mutagenesis: Target conserved residues to identify catalytic or binding sites

• Structural biology approaches: X-ray crystallography, cryo-EM, or NMR spectroscopy of the full protein or stable domains

• Domain-specific antibodies: Generate antibodies against predicted domains to study their accessibility and function

This multi-faceted approach would provide insights into ORFC's structure-function relationships even without prior knowledge of its specific molecular role.

What strategies can be employed to generate effective antibodies against uncharacterized ORFC protein?

For generating antibodies against uncharacterized ORFC protein, researchers should employ these methodological approaches:

• Recombinant protein expression: Express full-length ORFC or selected domains with affinity tags for purification, optimizing expression conditions to maintain protein solubility

• Synthetic peptide approach: Design peptides corresponding to predicted antigenic regions of ORFC, particularly targeting surface-exposed regions identified through bioinformatic analysis

• Multiple host species: Generate antibodies in multiple species (rabbit, mouse, chicken) to maximize epitope coverage

• Monoclonal and polyclonal development: Generate both monoclonal antibodies (for specificity) and polyclonal antibodies (for robust detection)

• Validation strategy: Test antibodies against bacteria expressing or lacking ORFC, and against recombinant ORFC protein

• Epitope mapping: Characterize the specific epitopes recognized by successful antibodies to aid in experimental design

This comprehensive approach increases the likelihood of generating functional antibodies against a previously uncharacterized protein.

What purification protocols are recommended for ORFC protein to use as an immunogen?

For purifying ORFC protein as an immunogen:

• Expression optimization: Test multiple expression systems (E. coli, cell-free systems) and conditions (temperature, induction time) to maximize soluble protein yield

• Fusion tags: Use solubility-enhancing tags (MBP, SUMO, thioredoxin) with cleavable linkers to improve purification without affecting immunogenicity

• Denaturing/refolding: If necessary, purify under denaturing conditions followed by controlled refolding

• Chromatography strategy:

  • Initial capture: Affinity chromatography based on fusion tag

  • Intermediate purification: Ion exchange chromatography

  • Polishing: Size exclusion chromatography to ensure homogeneity

• Quality control: Verify purity by SDS-PAGE and proper folding by circular dichroism before immunization

• Endotoxin removal: Include specific steps to remove bacterial endotoxins that could affect immunization

This systematic approach maximizes the chances of obtaining pure, properly folded ORFC protein suitable for antibody production.

How can researchers validate the specificity of anti-ORFC antibodies in bacterial lysates?

To validate anti-ORFC antibody specificity:

• Genetic controls: Test antibodies against lysates from:

  • Wild-type bacteria expressing ORFC

  • Isogenic mutants with ORFC deleted

  • Complemented strains with ORFC reintroduced

• Recombinant protein controls: Include purified recombinant ORFC as a positive control

• Competing antigens: Perform competition assays with the immunizing peptide/protein to confirm binding specificity

• Cross-reactivity testing: Test against related bacterial species with homologous proteins

• Multiple detection methods: Validate using different techniques:

  • Western blot under reducing and non-reducing conditions

  • Immunoprecipitation followed by mass spectrometry

  • Immunofluorescence microscopy

• Inducible expression: Use bacteria with inducible ORFC expression to confirm antibody detects expected changes in expression levels

This multi-faceted validation ensures that antibodies specifically recognize ORFC in complex bacterial samples.

What are the optimal fixation and permeabilization methods for immunolocalization of ORFC?

For immunolocalization of ORFC in bacteria:

• Fixation optimization:

  • Test paraformaldehyde (2-4%) for protein crosslinking while maintaining antigenicity

  • Compare with methanol fixation for structural protein preservation

  • Evaluate glutaraldehyde (0.05-0.1%) for enhanced structural preservation if needed

  • Optimize fixation time (10-30 minutes) to balance preservation and antibody accessibility

• Permeabilization methods:

  • Mild detergent permeabilization (0.1-0.2% Triton X-100 or 0.01-0.05% SDS)

  • Lysozyme treatment (1-10 μg/ml) for improved access to membrane-associated proteins

  • Optimization of permeabilization duration (5-15 minutes)

• Controls:

  • Include antibodies against proteins in different cellular compartments

  • Compare localization patterns with fluorescent protein fusions of ORFC

  • Use ORFC knockout strains as negative controls

These optimized protocols will enable accurate visualization of ORFC's subcellular localization during various experimental conditions.

How should western blot protocols be optimized for detection of low-abundance ORFC protein?

For detecting potentially low-abundance ORFC by western blot:

• Sample preparation:

  • Optimize lysis buffers to efficiently extract ORFC while preventing degradation

  • Consider subcellular fractionation to enrich for the fraction containing ORFC

  • Concentrate proteins using TCA precipitation (10-20%) to load more protein per lane

• Electrophoresis conditions:

  • Use gradient gels (4-20%) for optimal resolution

  • Extend transfer time (1-16 hours) with reduced voltage for efficient transfer of all protein sizes

• Blocking and antibody conditions:

  • Test different blocking agents (5% BSA, 5% milk, commercial blockers)

  • Optimize primary antibody concentration (typically 1:500-1:5000) and incubation conditions (4°C overnight)

  • Use high-sensitivity detection systems (enhanced chemiluminescence plus, fluorescent secondary antibodies)

• Signal enhancement:

  • Consider biotin-streptavidin amplification systems for very low abundance proteins

  • Use signal accumulation through extended imaging times with cooled CCD cameras

This optimized protocol maximizes sensitivity while maintaining specificity for ORFC detection.

How can researchers address non-specific binding issues with anti-ORFC antibodies?

To address non-specific binding of anti-ORFC antibodies:

• Blocking optimization:

  • Test different blocking agents (BSA, milk, commercial blockers, fish gelatin)

  • Increase blocking time (1-3 hours) and concentration (3-5%)

  • Add 0.1-0.3% Tween-20 to washing and antibody incubation buffers

• Antibody optimization:

  • Perform antibody titration to determine optimal concentration

  • Pre-adsorb antibodies with lysates from ORFC-knockout bacteria

  • Use affinity-purified antibodies against the specific antigen

• Sample preparation:

  • Include reducing agents (DTT, 2-mercaptoethanol) to minimize non-specific disulfide bonds

  • Pre-clear lysates by centrifugation (16,000 g for 15 minutes) to remove aggregates

  • Use more stringent washing conditions (higher salt concentration, 0.1% SDS)

• Controls:

  • Include competitive inhibition with immunizing antigen

  • Use secondary antibody-only controls to identify background

These systematic adjustments can significantly reduce non-specific binding while preserving specific ORFC detection.

What strategies help overcome expression difficulties when producing recombinant ORFC protein?

For addressing challenges in ORFC expression:

• Expression system optimization:

  • Test multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express, SHuffle)

  • Try alternative expression systems (insect cells, cell-free systems)

  • Optimize induction conditions (lower temperature, reduced IPTG concentration, longer expression time)

• Construct design:

  • Codon optimization for the expression host

  • Fusion partners that enhance solubility (MBP, SUMO, thioredoxin)

  • Test truncated constructs targeting stable domains

  • Modify N- or C-termini to remove potentially problematic regions

• Growth and induction protocols:

  • Use auto-induction media for gradual protein expression

  • Reduce growth temperature to 15-18°C during expression

  • Co-express with chaperones (GroEL/ES, DnaK/J, trigger factor)

• Extraction conditions:

  • Optimize lysis buffers with stabilizing additives (glycerol, specific salts, mild detergents)

  • Test enzymatic lysis versus mechanical disruption methods

This comprehensive approach addresses multiple factors that might limit successful ORFC expression.

How can researchers interpret contradictory data regarding ORFC function in different experimental systems?

When faced with contradictory data about ORFC function:

• Standardize experimental conditions:

  • Use consistent strain backgrounds and growth conditions

  • Standardize protein expression levels across systems

  • Control for genetic background effects through complementation

• Multiple assay approaches:

  • Validate findings using independent experimental techniques

  • Develop quantitative assays with appropriate statistical analysis

  • Use time-course experiments to capture dynamic effects

• Context-dependent analysis:

  • Systematically test environmental variables (temperature, media, growth phase)

  • Investigate genetic interactions that might alter ORFC function

  • Consider post-translational modifications in different conditions

• Mechanistic investigation:

  • Perform domain mapping to identify regions responsible for different activities

  • Use point mutations to separate different functions

  • Develop in vitro assays with purified components to confirm direct effects

These approaches help reconcile seemingly contradictory results by identifying the specific conditions under which different ORFC functions manifest.

What approaches help resolve precipitation problems during ORFC protein purification?

To address ORFC precipitation during purification:

• Buffer optimization:

  • Screen buffers across pH range (pH 5.5-9.0) to find optimal stability

  • Test various salt concentrations (50-500 mM NaCl) to minimize aggregation

  • Add stabilizing agents (5-10% glycerol, 0.5-1 M urea, 0.1-0.5 M arginine)

• Additive screening:

  • Test detergents below CMC (0.01-0.05% Triton X-100, 0.01-0.1% CHAPS)

  • Add reducing agents (1-5 mM DTT or TCEP) to prevent disulfide-mediated aggregation

  • Include protease inhibitors to prevent degradation-induced precipitation

• Physical parameters:

  • Maintain low protein concentration during initial purification steps

  • Control temperature consistently (typically 4°C) throughout purification

  • Use gentle mixing methods to avoid shear-induced aggregation

• Chromatography strategies:

  • Perform affinity purification rapidly to minimize time at high concentration

  • Use on-column refolding for proteins purified under denaturing conditions

  • Immediately apply to size exclusion chromatography after affinity steps

This systematic approach can significantly improve ORFC solubility and stability during purification.

How can researchers study the temporal dynamics of ORFC expression during phage infection?

To study ORFC expression dynamics during phage infection:

• Time-course experimental design:

  • Sample at multiple timepoints (0, 5, 10, 15, 30, 45, 60 minutes) after synchronized phage infection

  • Include both wild-type phages and retron-evading mutant phages

  • Compare with non-infected controls at each timepoint

• Multi-level analysis:

  • Transcript level: qRT-PCR or RNA-seq to monitor ORFC mRNA levels

  • Protein level: Western blot with anti-ORFC antibodies to track protein abundance

  • Localization: Immunofluorescence microscopy to monitor ORFC distribution

• Single-cell approaches:

  • Flow cytometry using fluorescently-tagged antibodies against ORFC

  • Time-lapse microscopy with fluorescent reporter fusions

  • Single-cell RNA-seq to capture cell-to-cell variability

• Data integration:

  • Correlate ORFC expression with phage replication markers

  • Develop mathematical models to describe the temporal dynamics

  • Compare with the dynamics of other retron components

This comprehensive approach provides detailed insights into how ORFC expression changes during the course of phage infection, potentially revealing its specific role in retron defense.